Tuesday, October 21, 2014 2:27:19 AM
------------------------------------------------
Harold Dvorak : 2014 Gairdner Lecture
“VPF/VEGF: Vascular permeability & pathological
angiogenesis in tumors, wounds & chronic inflammation”
Thursday, October 23, 2014
12 noon - 1:00 p.m.
Frederic Gaspard Theatre
Basic Medical Science Building
Bannatyne Campus
YOU AND A GUEST TO THE
Thursday, October 23, 2014
12 noon - 1:00 p.m.
Frederic Gaspard Theatre
Basic Medical Science Building
Bannatyne Campus
GAIRDNER LECTURE
PRESENTED BY HAROLD F. DVORAK MD
Mallinckrodt Distinguished Professor of Pathology, Harvard Medical School
Director, Center for Vascular Biology Research, Beth Israel Deaconess Medical Center
Recipient: Canada Gairdner International Award, 2014
2014
In 1983, Dr. Dvorak and his colleagues were the first to demonstrate that tumor cells secreted vascular
endothelial growth factor (VEGF), known at the time as vascular permeability factor or VPF. This seminal
discovery provided the molecular basis for the field of angiogenesis. Dr. Dvorak went on to make the
critically important observation that tumors behave like “wounds that do not heal” in that the vascular and
stromal responses they induce closely mimic those of healing wounds. More recently, his work has
characterized the different types of blood vessels that tumors generate and the molecular mechanisms by
which they form.
Dr. Dvorak has taught for many years at the Harvard Medical School, and has lectured frequently as a
visiting professor and at numerous national and international scientific conferences. He is a fellow of the
American Association for the Advancement of Science and of the National Foundation for Cancer Research
and has served as President of the American Society for Investigative Pathology which awarded him the
2002 Rous-Whipple award the Gold-headed cane award for his scientific accomplishments. In 2005 he
received the Grand Prix Lefoulon-Delalande from the Institut de France and in 2006 the inaugural Albert
Szent-Gyorgyi Prize for Progress in Cancer Research from the National Foundation for Cancer Research (NFCR).
----------------------------------------------------------
Collegiate students to take in lecture from renowned cancer researcher
Oct 20, 2014
Dr. Harold Dvorak will deliver his student lecture "What does cancer have to do with a cut finger?" on Thursday, October 23, at 2:30 pm.
http://www.noodls.com/view/4D1B622A3E08829B10236B733BA2293344DDA8E1?5529xxx1413835002
---------------------------------------------
October 30, 2014
9:40 am–10:10am (30 mins)
VPF/VEGF: Vascular permeability & pathological angiogenesis in tumors, wounds & chronic inflammation
Dr.Harold Dvorak 2014 Canada Gairdner International Laureate,
Beth Israel Deaconess Medical Center, Boston,
MA, USA
1:05 am-1:35pm(30 mins)
Targeting immune checkpoints in cancer therapy
Dr. James Allison 2014 Canada Gairdner International Laureate,
University of Texas, Houston, USA
http://www.gairdner.org/sites/default/files/downloads/2014_canada_gairdner_recipients_lecture_october_30_2014pdf.pdf
http://www.gairdner.org/content/about-our-events
-----------------------------------------------------------
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:33:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:32:11 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM